About this trial
Skin diseases, despite low mortality, significantly impair quality of life. This randomised controlled trial evaluates the efficacy of a digital toolkit comprising psychotherapeutic strategies in reducing QoL burden in patients with chronic inflammatory skin conditions. This toolkit is hosted on a mobile application and will be used by study participants randomised to the intervention arm over the 32 week study period.
Eligibility criteria
Qualifiers
Patients with psoriasis, eczema or chronic urticaria diagnosed by a dermatologist
Aged 16 or older
Peak pruritus intensity of 4 or more on a 11-point numerical rating scale (0-10, with 10 representing worst itch)
Able to engage with a mobile application in the English language
Disqualifiers
Patients with active psychiatric symptoms (e.g. active suicidal ideation, psychosis, delusions)
Patients with unstable psychiatric condition, characterized by
Patients with unstable dermatological condition, characterized by
Recent flare of the skin condition within the last 2 weeks, including diagnosis of a flare by a doctor, use of systemic steroids, oral antibiotics, wet wrap rescue therapy, oral antivirals, or increase in frequency of phototherapy or dose of systemic medications for the dermatological condition within the last 2 weeks OR
Trial design
Treatments tested in this trial
- Digital psychotherapeutic intervention
- Healthy365
Treatment groups
Sponsors and collaborators
National University Hospital, Singapore
Lead sponsor
National Skin Centre, Singapore
Collaborator
National University of Singapore
Collaborator
KK Women's and Children's Hospital
Collaborator